
    
      A Randomized, Double-blind, Active-controlled, Multicenter phase 3 Clinical trial to evaluate
      the Efficacy and Safety of Concomitant Mometasone furoate and Levocabastine HCl in Perennial
      Allergic Rhinitis patients
    
  